StockData
Biomerica Inc logo

Biomerica Inc (BMRA) income statement

BMRANasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends May 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Aug 31, 2026Last filing: 10-Q on Oct 15, 2026Score 8/3055% below fair value
$1.09−0.15 (-11.74%)

Close on Nov 18, 2026Market cap $5.01MP/E –Yield –

Biomerica Inc income statement

Ratios

Latest available, balances at Aug 31, 2026

Profitability, TTM

Gross margin
0.9%
Operating margin
-125.2%
Net margin
-115.5%
Return on equity, FY2026
-112.1%

Financial strength

Current ratio
1.91
Debt to equity
–
Debt to assets
–
Cash to current liabilities
96.3%

Valuation

P/E ratio
–
Price to sales
1.16
Price to book
1.37
Dividend yield
–

See a number that looks wrong?